In addition, ITK deficiency in CAR-T cells derived from CLL patients attenuated T cell exhaustion, a critical issue in CLL patients (35), thereby potentially addressing a challenge in CAR-T cell therapy for CLL patients. Here, ITK is linked to B-cell chronic lymphocytic leukemia.